HEALTHbeat Sign Up Now For
HEALTHbeat
Our FREE E-mail Newsletter

Sign up for our FREE email newsletter and receive a FREE report, Living to 100: What's the secret?

You'll receive weekly briefings with health information you can trust from the doctors at Harvard Medical School.

Harvard Health Publications
The Harvard Medical School Family Health Guide


Harvard Health Publications
Order the Book
Contact Us

Sign up for our free e-mail newsletter, HEALTHbeat.  
Email address:
 
 
Special Health Information Reports
Incontinence
Weight Loss
Prostate Disease
Vitamins and Minerals
Aching Hands
See All Titles
About the Book
New Information
About the Team
Order the Book
Return to the Family Health Guide Home Page
  Harvard Health Publications
contact us

March 2001 :


New Medication Approved to Treat Eczema
Atopic dermatitis
is a chronic, hereditary skin condition that causes redness, itching, and oozing lesions. It mainly affects children but can persist into adulthood. Doctors often prescribe oral or topical corticosteroids for serious cases. But while steroids are very effective at quieting inflammation, they can have adverse side effects. Steroid creams may cause thinning of the skin and decreased collagen production, while oral corticosteroids can have more serious adverse effects.

Now, dermatologists have high hopes for a new ointment, tacrolimus (Protopic), which was recently approved by the FDA to treat moderate to severe eczema in patients who cannot tolerate or are not adequately helped by standard therapies. The FDA approved tacrolimus on the basis of three 12-week studies that found 90% improvement in about one-third of the patients who used the medication. Two additional one-year studies, also considered by the FDA, found that adults who used the drug intermittently over the course of the year had no adverse effects except temporary burning and stinging. Because tacrolimus can increase sensitivity to ultraviolet (UV) light, users should avoid sunlight, tanning beds, and treatment with UVA or UVB light.
March 2001 Update

Back to Top

Does Aspirin Prevent Preeclampsia?
Preeclampsia
, also known as toxemia, is a condition that affects pregnant women and their unborn baby. It is characterized by high blood pressure, water retention, and protein in the urine. The condition, which usually occurs after the 5th month of pregnancy, can lead to seizures, kidney and liver damage, slow fetal growth, and even fetal or maternal death. Preeclampsia affects up to 8% of pregnancies, and is responsible for 10-15% of maternal deaths. In the past decade, several studies have looked at the effectiveness of aspirin in preventing preeclampsia.

Early studies showed promising results. But larger, more recent studies failed to show any benefit.

In an effort to reconcile these conflicting results, British researchers reviewed several studies involving over 30,000 women who were at increased risk for preeclampsia. (Risk factors include preexisting high blood pressure, diabetes, a first pregnancy, pregnancy as a teenager or over the age of 40, and pregnancy involving multiple fetuses.) The women had been randomized to receive an antiplatelet drug (usually low-dose aspirin), a placebo, or no antiplatelet medication.

The researchers concluded that aspirin reduced the risk of preeclampsia by 15%. Their review also showed that aspirin decreased the risk of premature births by 8% and the risk of stillbirths or newborn deaths by 14%. Based on these results
acknowledged by the researchers as showing only small to moderate benefits the researchers recommended the use of aspirin. Several issues including the optimal dosage, the proper time to start treatment, and which women are most likely to benefit, remain unresolved.

Despite the results of this review, some leading experts are unconvinced that aspirin is effective at preventing preeclampsia. However, even physicians who doubt aspirin's efficacy agree that at doses of less than 80 milligrams per day, aspirin is not harmful. If your physician prescribes aspirin to prevent preeclampsia, it may or may not be effective
but in any case, it won't be harmful.
March 2001 Update

Back to Top

Comparing the Side Effects of Prostatectomy vs. Radiation Therapy
Prostate cancer is the most commonly diagnosed non-skin cancer among men in the United States. When caught early, it is also among the most treatable. Two of the more aggressive
and common methods of treatment for early stage prostate cancer are radiation therapy and surgery (radical prostatectomy) to remove the prostate gland. Although both options have favorable outcomes, physicians have not reached a consensus on which therapy is more effective. This means that men who are treated with either surgery or radiation can usually expect to live for many more years. The caveat is that they often have to live with the side effects of their treatment. Deciding on a treatment option, then, becomes a question of which side effects are more likely with each therapy, and also which side effects are more tolerable to a particular patient.

A recent analysis of data from the Prostate Cancer Outcomes Study helps to clarify this issue by comparing the side effects of the two therapies in men between the ages of 55 and 74, two years after treatment. The results showed that men in both treatment groups experienced significant decreases in sexual function. Of the men in the surgery group, 80% became impotent, compared to 62% of the men in the radiation group. Age and status of sexual function prior to treatment affected these outcomes. Twelve percent of the men who underwent surgery experienced dripping or leaking urine, compared to only 2% of the men who had radiation therapy. Few men in either group were bothered by bowel problems. Of the men who were affected, however, radiation patients experienced more diarrhea, bowel urgency, and painful hemorrhoids (33%, 30%, and 19%, respectively) compared to surgery patients (22%, 16%, and 10%).

Overall, this study showed that men who opt for surgery can expect to have more urinary and sexual problems, while men who choose radiation are more likely to suffer from bowel disturbances. A man's age and initial health are also important factors in the development and duration of long-term side effects from either treatment. Physicians and their patients should use this information, as well as a discussion of the patient's priorities, preferences, and concerns, to help decide which treatment method is appropriate.
March 2001 Update

Back to Top

Pneumonia: How Long Before You Feel Better?
Pneumonia is a serious infection or inflammation of the lungs. Uncomplicated pneumonia may be successfully treated with antibiotics in one or two weeks, but many patients continue to experience the symptoms of pneumonia, including cough, chest pain, fatigue, shortness of breath, and fever, for some time after that. A team of Canadian researchers set out to determine how long after treatment it should take for pneumonia patients to be symptom-free.

The scientists asked a group of 535 adults who had undergone a course of antibiotic treatment for pneumonia to complete questionnaires about persisting symptoms at two and six weeks after the completion of their treatment.

The average age of these patients was 62 years. Fifty-four percent of the patients were admitted to the hospital for treatment of their pneumonia, while a minority had a coexisting chronic illness such as chronic obstructive pulmonary disease (26%), asthma (17%), or congestive heart failure (12%).

At two weeks after therapy, 67% of patients reported fatigue, 56% were coughing, 50% were short of breath, and 35% were producing sputum. Six weeks after therapy, more than 60% of patients reported continuing symptoms. Forty-five percent still had fatigue, 35% continued to cough, and 16% had gastrointestinal symptoms. Older patients, those who were sickest at onset of treatment, patients with chronic obstructive pulmonary disease, and patients with asthma suffered the most persistent symptoms.

Although hospitalizations are shorter and antibiotic treatments briefer, complete recovery still takes time. Pneumonia patients should be reassured that a "normal" period of recuperation may vary from several weeks to several months.
March 2001 Update

Back to Top

Reducing Your Risk of Deep Vein Thrombosis During Airline Travel
Deep vein thrombosis (DVT), recently featured in the news as "economy class syndrome," is the formation of a blood clot in the deep veins of the legs while sitting — particularly in the cramped seats of an airplane (be it economy class or first class), car, bus, or train — for long periods. You move less in tight quarters, causing circulation to decrease and allowing blood to collect and form a clot. The blood clot may cause pain and swelling in the legs. Serious, even fatal complications can occur if the blood clot breaks loose in the blood stream and travels to the heart or lungs. Older people, and those who are obese or have a family history of DVT tend to be at the highest risk.

While a blood clot can result from a number of causes, some studies suggest an association between blood clots and airplane travel. Many doctors believe this connection is simply a result of being unable to move around, and not from sitting in economy class seats or in an airplane, per se. However, it is possible that pressurized air and dehydration may also play a role in the connection between air travel and blood clots.

Many airlines have already begun to address this health issue by preparing warning pamphlets for their passengers, including articles in their in-flight magazines, posting notices on their websites, or creating in-flight videos offering exercises aimed at prevention. A member of the parliament in Australia has even called for treadmills to be installed in airplanes that carry passengers for six or more hours.

While treadmills may or may not appear on airplanes in the near future, you can address this issue on your next lengthy flight by taking a few simple measures to help prevent blood clotting.

  • Wear loose-fitting, comfortable clothing during the flight.

  • Eat a small meal and drink plenty of fluids to help increase blood circulation. Avoid alcohol and caffeine, as these contribute to dehydration.

  • Do not cross your legs while seated and make sure you adjust your position every half hour.

  • You may want to wear elastic support hose to increase circulation in your legs.

  • Most importantly, try to walk up and down the aisle at least once an hour. Even standing in front of your seat and gently shaking out your legs or slowly rising up on your toes can help.

  • If you can’t get out of your seat, you can do the following exercises in your seat to increase blood circulation. Perform each exercise for 15 seconds, once an hour.

    • Ankle rotations: Draw a circle with your toes, rotating clockwise and then counterclockwise with both feet.

    • Foot pumps: Slowly alternate between flexing and pointing your toes.

    • Leg lifts: With your knee bent, lift your leg up off the seat and hold for a few seconds. Alternate legs.

    • Head and shoulder rotations: Gently roll your head clockwise and then counterclockwise, keeping your shoulders relaxed. Then gently roll your shoulders forwards and backwards.

    • Toe reach: Slowly bend forward and extend your arms down towards your toes and then gently sit back up.

  • People who are at high risk for blood clotting due to other conditions should speak with their physician for additional advice before traveling.

Studies do not agree on how long a flight needs to be to pose a risk of blood clotting. A few studies even suggest that there is no association between blood clots and air travel. Clearly, more research is necessary. However, while we wait for a definitive answer to these questions, heeding these simple instructions may help prevent problems.
March 2001 Update

Back to Top

 



©2000–2006 President & Fellows of Harvard College